Decision of the EEA Joint Committee No 204/2024 of 23 September 2024 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/3058]
Date: 2024-09-23
Institutions: EEA Joint Committee
Subjects: European Economic Area, biocide, chemical product, health risk, insecticide, market approval, marketing standard, revision of an agreement, rodent, toxic substance




L_202403058EN.000101.fmx.xml












Official Journal of the European Union


EN
L series













2024/3058


19.12.2024







            DECISION OF THE EEA JOINT COMMITTEE No 204/2024
of 23 September 2024
         
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/3058]


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:







(1)


Commission Implementing Decision (EU) 2024/734 of 27 February 2024 postponing the expiry date of the approval of brodifacoum, bromadiolone, chlorophacinone, coumatetralyl, difenacoum, difethialone and flocoumafen for use in biocidal products of product-type 14 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (1) is to be incorporated into the EEA Agreement.












(2)


Commission Implementing Decision (EU) 2024/731 of 28 February 2024 postponing the expiry date of the approval of indoxacarb for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (2) is to be incorporated into the EEA Agreement.












(3)


Commission Implementing Decision (EU) 2024/732 of 28 February 2024 postponing the expiry date of the approval of aluminium phosphide for use in biocidal products of product-types 14 and 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (3) is to be incorporated into the EEA Agreement.












(4)


Commission Implementing Decision (EU) 2024/733 of 28 February 2024 postponing the expiry date of the approval of cholecalciferol for use in biocidal products of product-type 14 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (4) is to be incorporated into the EEA Agreement.












(5)


Commission Implementing Decision (EU) 2024/787 of 28 February 2024 postponing the expiry date of the approval of magnesium phosphide for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (5) is to be incorporated into the EEA Agreement.












(6)


Commission Implementing Decision (EU) 2024/816 of 5 March 2024 addressing questions regarding the second comparative assessment of anticoagulant rodenticide biocidal products in accordance with Article 23(5) of Regulation (EU) No 528/2012 of the European Parliament and of the Council (6) is to be incorporated into the EEA Agreement.












(7)


Annex II to the EEA Agreement should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
Chapter XV of Annex II to the EEA Agreement shall be amended as follows:






1.


The following point is inserted after point 12nnz (Commission Implementing Decision (EU) 2016/1175):






‘12nnna.



32024 D 0816: Commission Implementing Decision (EU) 2024/816 of 5 March 2024 addressing questions regarding the second comparative assessment of anticoagulant rodenticide biocidal products in accordance with Article 23(5) of Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2024/816, 7.3.2024).’














2.


The following points are inserted after point 12zzzzzzzzzzm (Commission Implementing Regulation (EU) 2024/893):






‘12zzzzzzzzzzn.



32024 D 0734: Commission Implementing Decision (EU) 2024/734 of 27 February 2024 postponing the expiry date of the approval of brodifacoum, bromadiolone, chlorophacinone, coumatetralyl, difenacoum, difethialone and flocoumafen for use in biocidal products of product-type 14 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2024/734, 29.2.2024).










12zzzzzzzzzzo.



32024 D 0731: Commission Implementing Decision (EU) 2024/731 of 28 February 2024 postponing the expiry date of the approval of indoxacarb for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2024/731, 1.3.2024).










12zzzzzzzzzzp.



32024 D 0732: Commission Implementing Decision (EU) 2024/732 of 28 February 2024 postponing the expiry date of the approval of aluminium phosphide for use in biocidal products of product-types 14 and 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2024/732, 1.3.2024).










12zzzzzzzzzzq.



32024 D 0733: Commission Implementing Decision (EU) 2024/733 of 28 February 2024 postponing the expiry date of the approval of cholecalciferol for use in biocidal products of product-type 14 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2024/733, 1.3.2024).










12zzzzzzzzzzr.



32024 D 0787: Commission Implementing Decision (EU) 2024/787 of 28 February 2024 postponing the expiry date of the approval of magnesium phosphide for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2024/787, 4.3.2024).’










Article 2
The texts of Implementing Decisions (EU) 2024/734, (EU) 2024/731, (EU) 2024/732, (EU) 2024/733, (EU) 2024/787 and (EU) 2024/816 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 3
This Decision shall enter into force on 24 September 2024, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).


Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 23 September 2024.


For the EEA Joint Committee


The President

Anders H. EIDE
            





(1)  
            OJ L, 2024/734, 29.2.2024, ELI: http://data.europa.eu/eli/dec_impl/2024/734/oj.

(2)  
            OJ L, 2024/731, 1.3.2024, ELI: http://data.europa.eu/eli/dec_impl/2024/731/oj.

(3)  
            OJ L, 2024/732, 1.3.2024, ELI: http://data.europa.eu/eli/dec_impl/2024/732/oj.

(4)  
            OJ L, 2024/733, 1.3.2024, ELI: http://data.europa.eu/eli/dec_impl/2024/733/oj.

(5)  
            OJ L, 2024/787, 4.3.2024, ELI: http://data.europa.eu/eli/dec_impl/2024/787/oj.

(6)  
            OJ L, 2024/816, 7.3.2024, ELI: http://data.europa.eu/eli/dec_impl/2024/816/oj.

(*1)  No constitutional requirements indicated.


ELI: http://data.europa.eu/eli/dec/2024/3058/oj
ISSN 1977-0677 (electronic edition)